Clinical trialNCT01193504UnknownPhase 4Interventional

Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification

SponsorInnovative MedicalEnrollment100Cataract SurgeryPseudophakia

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine if Lotemax eye drops are at least as effective as Pred Forte eye drops, which are the standard of care after cataract surgery.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Bonnie Henderson, MD
Ophthalmic Consultants of Boston
Principal Investigator
clinicaltrials.gov ↗
John Hovanesian, MD
Harvard Eye Associates
Principal Investigator
clinicaltrials.gov ↗
William Trattler, MD
The Center for Excellence in Eye Care
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Harvard Eye Associates
Laguna Hills, California, United States
John Hovanesian, MD
Recruiting
the Center for Excellence in Eye Care
Miami, Florida, United States
Carlos Buznego, MDWilliam Trattler, MD
Recruiting
Ophthalmic Consultants of Boston
Waltham, Massachusetts, United States
Completed

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Loteprednol etabonate →Pred Forte

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Sept 2010
Primary completion: 31 Oct 2012
Completion: 31 Oct 2012
Last update posted: 14 Jun 2012
Registered enrollment: 100
Registry id: NCT01193504

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.